
Ms Nermina Buljubasic
Erasmus University Medical Centre, Rotterdam (Netherlands (The))
Follow
Contributor content
Presentation
Multiple vascular endothelial growth factor (-receptor) polymorphisms modify the treatment benefit of ACE-inhibitors on cardiovascular outcome
Presentation

